Rossari Biotech's ROE % for the quarter that ended in Mar. 2026 was 13.79%. Rossari Biotech's PB Ratio for the quarter that ended in Mar. 2026 was 1.57.
Rossari Biotech's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was 8.78%.
Rossari Biotech ROE % Adjusted to Book Value Related Terms
Rossari Biotech ROE % Adjusted to Book Value Historical Data
* Premium members only.
The historical data trend for Rossari Biotech's ROE % Adjusted to Book Value can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rossari Biotech ROE % Adjusted to Book Value Chart
NSE:ROSSARI vs LIN, SHW, ECL: ROE % Adjusted to Book Value Comparison
For the Specialty Chemicals subindustry, Rossari Biotech's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Rossari Biotech ROE % Adjusted to Book Value vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Rossari Biotech's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Rossari Biotech's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of 8.78% mean?
Rossari Biotech (NSE:ROSSARI) has a ROE % Adjusted to Book Value of 8.78% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Rossari Biotech and its competitors.
Is Rossari Biotech's ROE % Adjusted to Book Value too high?
Rossari Biotech's current ROE % Adjusted to Book Value is 8.78%. Overall, Rossari Biotech has a GF Score™ of 85/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Rossari Biotech's ROE % Adjusted to Book Value compare to LIN and SHW?
Rossari Biotech's ROE % Adjusted to Book Value of 8.78% can be compared against companies in the Chemicals industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Chemicals company?
A good ROE % Adjusted to Book Value depends on the Chemicals industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Rossari Biotech and its competitors. Rossari Biotech's current ROE % Adjusted to Book Value is 8.78%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Rossari Biotech stock overvalued right now?
Based on GuruFocus' analysis, Rossari Biotech (NSE:ROSSARI) is currently considered Possible Value Trap. The stock's GF Value™ is ₹1,001.07, compared to a current price of ₹523.90 — trading 47.7% below its estimated fair value. The current ROE % Adjusted to Book Value is 8.78%. Rossari Biotech's overall GF Score™ is 85/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Rossari Biotech (NSE:ROSSARI), the current ROE % Adjusted to Book Value is 8.78% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Rossari Biotech (NSE:ROSSARI) Overvalued in 2026?
Based on GuruFocus' analysis, Rossari Biotech stock appears to be undervalued.
The current stock price of ₹523.90 is trading 47.7% below its estimated GF Value™ of ₹1,001.07.
GuruFocus considers Rossari Biotech to be Possible Value Trap.
Key valuation signals for NSE:ROSSARI:
ROE % Adjusted to Book Value: 8.78%
GF Value™: ₹1,001.07 vs. price of ₹523.90 (47.7% below fair value)
No single metric tells the full story. See the NSE:ROSSARI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Rossari Biotech Ltd is a specialty chemical manufacturing company. It provides customized solutions to specific industrial and production requirements of its customers in the FMCG, apparel, poultry, and animal feed industries through its product portfolio comprising home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its business is organized into three categories: home, personal care, and performance chemicals; textile specialty chemicals; and animal health and nutrition products. Its products include soaps and detergents, paints, inks and coatings, ceramics and tiles, water treatment chemicals, pulp and paper, and cleaning chemical formulations, among others. The company generates the majority revenue from India.
85GF Score
Get the complete analysis for NSE:ROSSARI
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
NSE:ROSSARI has been successfully added to your 
